Anaemia, Haemoglobin level and cause-specific mortality in people with and without diabetes

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Kengne, Andre Pascal ^a,b,c   Czernichow, Sébastien ^d,e   Hamer, Mark ^f   Batty, G David ^f   Stamatakis, Emmanuel ^f  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^d Ambroise Paré Hospital AP HP   (France)

^e LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADULT; ANEMIA; ARTICLE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CAUSE SPECIFIC MORTALITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HAZARD RATIO; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; STROKE; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; FEMALE; HEMOGLOBINS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK; SENSITIVITY AND SPECIFICITY;

EID: 84864459219     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041875     Document Type: Article

References (35)

1. McFarlane SI, Salifu MO, Makaryus J, Sowers JR, ((2006)) Anemia and cardiovascular disease in diabetic nephropathy. Current diabetes reports 6:: 213--218.
2. Deray G, Heurtier A, Grimaldi A, Launay Vacher V, Isnard Bagnis C, ((2004)) Anemia and diabetes. American journal of nephrology 24:: 522--526.
3. Davis MD, Fisher MR, Gangnon RE, Barton F, Aiello LM, et al. ((1998)) Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. Investigative ophthalmology & visual science 39:: 233--252.
4. Qiao Q, Keinanen-Kiukaanniemi S, Laara E, ((1997)) The relationship between hemoglobin levels and diabetic retinopathy. Journal of clinical epidemiology 50:: 153--158.
5. Fishbane S, ((2008)) Anemia and cardiovascular risk in the patient with kidney disease. Heart failure clinics 4:: 401--410.
6. Sarnak MJ, Tighiouart H, Manjunath G, MacLeod B, Griffith J, et al. ((2002)) Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study. Journal of the American College of Cardiology 40:: 27--33.
7. Zoppini G, Targher G, Chonchol M, Negri C, Stoico V, et al. ((2010)) Anaemia, independent of chronic kidney disease, predicts all-cause and cardiovascular mortality in type 2 diabetic patients. Atherosclerosis 210:: 575--580.
8. Vlagopoulos PT, Tighiouart H, Weiner DE, Griffith J, Pettitt D, et al. ((2005)) Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease. Journal of the American Society of Nephrology: JASN 16:: 3403--3410.
9. Tong PC, Kong AP, So WY, Ng MH, Yang X, et al. ((2006)) Hematocrit, independent of chronic kidney disease, predicts adverse cardiovascular outcomes in chinese patients with type 2 diabetes. Diabetes care 29:: 2439--2444.
10. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M, ((1998)) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:: 229--234.
11. Kengne AP, Batty GD, Hamer M, Stamatakis E, Czernichow S, ((2012)) Association of C-reactive protein with cardiovascular disease mortality according to diabetes status: pooled analyses of 25,979 participants from four U.K. prospective cohort studies. Diabetes care 35:: 396--403.
12. Czernichow S, Kengne AP, Stamatakis E, Hamer M, Batty GD, ((2011)) Body mass index, waist circumference and waist-hip ratio: which is the better discriminator of cardiovascular disease mortality risk?: evidence from an individual-participant meta-analysis of 82 864 participants from nine cohort studies. Obesity reviews: an official journal of the International Association for the Study of Obesity 12:: 680--687.
13. Dong W, Erens B, ((1997)) editors ((1997)) Scottish Health Survey 1995. Edinburg: The Scottish Office Department of Health.
14. Shaw A, McMunn A, Field J, ((2000)) editors ((2000)) The Scottish Health Survey 1998. Edinburg: The Scottish Executive Department of Health.
15. The UK Department of Health (1999) The Health Survey for England 1998: Cardiovascular Disease. (Erens B, Primatesta P, editors.). London: The Stationary Office.
16. World Health Organization (1972) Nutritional Anaemias, Technical Report Series 503. Geneva: WHO.
17. Easton DF, Peto J, Babiker AG, ((1991)) Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. Stat Med 10:: 1025--1035.
18. Collett D (2003) Modelling survival data in medical research. Chatfield C, Tanner M, Zidek J, editors. New York: Chapman & Hall/CRC. 391 p.
19. Gonzalez-Clemente JM, Palma S, Arroyo J, Vilardell C, Caixas A, et al. ((2007)) Is Diabetes Mellitus a Coronary Heart Disease Equivalent? Results of a Meta-Analysis of Prospective Studies. Rev Esp Cardiol 60:: 1167--1176.
20. Bulugahapitiya U, Siyambalapitiya S, Sithole J, Idris I, ((2009)) Is diabetes a coronary risk equivalent? Systematic review and meta-analysis. Diabet Med 26:: 142--148.
21. Al Falluji N, Lawrence-Nelson J, Kostis JB, Lacy CR, Ranjan R, et al. ((2002)) Effect of anemia on 1-year mortality in patients with acute myocardial infarction. American heart journal 144:: 636--641.
22. Pereira AA, Sarnak MJ, ((2003)) Anemia as a risk factor for cardiovascular disease. Kidney international. Supplement: S32-39.
23. Lipsic E, van der Horst IC, Voors AA, van der Meer P, Nijsten MW, et al. ((2005)) Hemoglobin levels and 30-day mortality in patients after myocardial infarction. International journal of cardiology 100:: 289--292.
24. Chonchol M, Nielson C, ((2008)) Hemoglobin levels and coronary artery disease. American heart journal 155:: 494--498.
25. Astor BC, Muntner P, Levin A, Eustace JA, Coresh J, ((2002)) Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994). Archives of internal medicine 162:: 1401--1408.
26. Bhatia V, Chaudhuri A, Tomar R, Dhindsa S, Ghanim H, et al. ((2006)) Low testosterone and high C-reactive protein concentrations predict low hematocrit in type 2 diabetes. Diabetes care 29:: 2289--2294.
27. Redondo-Bermejo B, Pascual-Figal DA, Hurtado-Martinez JA, Montserrat-Coll J, Penafiel-Verdu P, et al. ((2007)) [Clinical determinants and prognostic value of hemoglobin in hospitalized patients with systolic heart failure]. Revista espanola de cardiologia 60:: 597--606.
28. Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Tonelli M, et al. ((2010)) Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Annals of internal medicine 153:: 23--33.
29. Phrommintikul A, Haas SJ, Elsik M, Krum H, ((2007)) Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis. Lancet 369:: 381--388.
30. Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, et al. ((2009)) A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. The New England journal of medicine 361:: 2019--2032.
31. Unger EF, Thompson AM, Blank MJ, Temple R, ((2010)) Erythropoiesis-stimulating agents-time for a reevaluation. The New England journal of medicine 362:: 189--192.
32. Bohlius J, Schmidlin K, Brillant C, Schwarzer G, Trelle S, et al. ((2009)) Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials. Lancet 373:: 1532--1542.
33. van der Meer P, Groenveld HF, Januzzi JL Jr, van Veldhuisen DJ, ((2009)) Erythropoietin treatment in patients with chronic heart failure: a meta-analysis. Heart 95:: 1309--1314.
34. Moons K, Kengne AP, Woodward M, Royston P, Vergouwe Y, et al. ((2012)) Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker. Heart. doi:10.1136/heartjnl-2011-301246.
35. American Diabetes Association, ((2011)) Standards of medical care in diabetes-2011. Diabetes care 34:: S11--61.